000 | 01971 a2200517 4500 | ||
---|---|---|---|
005 | 20250515155154.0 | ||
264 | 0 | _c20090330 | |
008 | 200903s 0 0 eng d | ||
022 | _a1078-0432 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-08-1095 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaniel, Rachel A | |
245 | 0 | 0 |
_aInhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2009 |
||
300 |
_a1241-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
650 | 0 | 4 | _aPoly (ADP-Ribose) Polymerase-1 |
650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
650 | 0 | 4 | _aTemozolomide |
650 | 0 | 4 |
_aTopotecan _xpharmacology |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aRozanska, Agata L | |
700 | 1 | _aThomas, Huw D | |
700 | 1 | _aMulligan, Evan A | |
700 | 1 | _aDrew, Yvette | |
700 | 1 | _aCastelbuono, Deborah J | |
700 | 1 | _aHostomsky, Zdenek | |
700 | 1 | _aPlummer, E Ruth | |
700 | 1 | _aBoddy, Alan V | |
700 | 1 | _aTweddle, Deborah A | |
700 | 1 | _aCurtin, Nicola J | |
700 | 1 | _aClifford, Steven C | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 15 _gno. 4 _gp. 1241-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-08-1095 _zAvailable from publisher's website |
999 |
_c18620616 _d18620616 |